BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 11911277)

  • 21. A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
    Wang B; Wu M; Perchellet EM; McIlvain CJ; Sperfslage BJ; Huang X; Tamura M; Stephany HA; Hua DH; Perchellet JP
    Int J Oncol; 2001 Dec; 19(6):1169-78. PubMed ID: 11713586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of tetra-mu-carboxylatodirhodium(II) in L1210 tumor suspension culture.
    Howard RA; Kimball AP; Bear JL
    Cancer Res; 1979 Jul; 39(7 Pt 1):2568-73. PubMed ID: 445459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
    Wang JJ; Chervinsky DS; Rosen JM
    Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of chartreusin on cell survival and cell cycle progression.
    Bhuyan BK; Robinson MI; Shugars KD; Bono VH; Dion RL
    Cancer Res; 1978 Sep; 38(9):2734-9. PubMed ID: 567096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity and mode of action of substituted indan-1, 3-diones in murine and human tissue cultured cells.
    Hall IH; Wong OT; Chi LK; Chen SY
    Anticancer Res; 1994; 14(5A):2053-8. PubMed ID: 7847849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.
    Kanter PM; Schwartz HS
    Cancer Res; 1979 Sep; 39(9):3661-72. PubMed ID: 476691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells.
    Nagata T; Higashigawa M; Shimono Y; Cao DC; Yan Mao X; M'soka T; Inamochi H; Hori H; Kawasaki H; Sakurai M
    J Exp Clin Cancer Res; 1998 Dec; 17(4):435-42. PubMed ID: 10089064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
    Cass CE; Au-Yeung TH
    Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity of ribo-and arabinoside boron nucleosides in tissue culture cells.
    Sood A; Spielvogel BF; Powell WJ; Bastow KF; Miller MC; Hall IH
    Anticancer Res; 1994; 14(4A):1483-8. PubMed ID: 7979174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxicity, cellular uptake and DNA damage by daunorubicin and its new analogues with modified daunosamine moiety.
    Ciesielska E; Studzian K; Wasowska M; Oszczapowicz I; Szmigiero L
    Cell Biol Toxicol; 2005; 21(3-4):139-47. PubMed ID: 16328893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage.
    Oh SH; Lee BH
    Toxicol Appl Pharmacol; 2004 Feb; 194(3):221-9. PubMed ID: 14761678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.
    Ogawa A; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1998 Dec; 41(25):5094-107. PubMed ID: 9836625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CC-1065 (NSC 298223), a novel antitumor agent that interacts strongly with double-stranded DNA.
    Li LH; Swenson DH; Schpok SL; Kuentzel SL; Dayton BD; Krueger WC
    Cancer Res; 1982 Mar; 42(3):999-1004. PubMed ID: 6174220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis-inducing active components from Corbicula fluminea through activation of caspase-2 and production of reactive oxygen species in human leukemia HL-60 cells.
    Huang YT; Huang YH; Hour TC; Pan BS; Liu YC; Pan MH
    Food Chem Toxicol; 2006 Aug; 44(8):1261-72. PubMed ID: 16545898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
    Bhuyan BK; Fraser TJ; Day KJ
    Cancer Res; 1977 Apr; 37(4):1057-63. PubMed ID: 139202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel substituted 1,4-anthracenediones with antitumor activity directly induce permeability transition in isolated mitochondria.
    Perchellet EM; Wang Y; Lou K; Zhao H; Battina SK; Hua DH; Perchellet JP
    Int J Oncol; 2007 Nov; 31(5):1231-41. PubMed ID: 17912452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity of new N-substituted daunorubicin derivatives.
    Mazerska Z; Woynarowska B; Stefanska B; Borowski E; Martelli S
    Drugs Exp Clin Res; 1987; 13(6):345-51. PubMed ID: 3308387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
    Li ZR; Feng JB; Liang F; Zeng SX; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
    [No Abstract]   [Full Text] [Related]  

  • 39. Biological and biochemical effects of chartreusin on mammalian cells.
    Li LH; Clark TD; Murch LL; Wooden JM; Pschigoda LM; Krueger WC
    Cancer Res; 1978 Sep; 38(9):3012-8. PubMed ID: 567097
    [No Abstract]   [Full Text] [Related]  

  • 40. CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival.
    Bhuyan BK; Newell KA; Crampton SL; Von Hoff DD
    Cancer Res; 1982 Sep; 42(9):3532-7. PubMed ID: 7105029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.